Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-072475
Filing Date
2022-06-17
Accepted
2022-06-17 17:26:24
Documents
2
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2218797d1_6k.htm 6-K 13473
2 EXHIBIT 99.1 tm2218797d1_ex99-1.htm EX-99.1 286705
  Complete submission text file 0001104659-22-072475.txt   301125
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 221025168
SIC: 2834 Pharmaceutical Preparations